MedSciences Capital http://www.medsciencescapital.com MedSciences Capital Thu, 10 May 2012 10:56:08 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Mucosis announces positive proof-of-concept data for Mimopath® platform in humans http://www.medsciencescapital.com/news/mucosis-announces-positive-proof-of-concept-data-for-mimopath-platform-in-humans/ http://www.medsciencescapital.com/news/mucosis-announces-positive-proof-of-concept-data-for-mimopath-platform-in-humans/#comments Thu, 10 May 2012 10:39:42 +0000 piet http://www.medsciencescapital.com/?p=1152 http://www.medsciencescapital.com/news/mucosis-announces-positive-proof-of-concept-data-for-mimopath-platform-in-humans/feed/ 0 Mucosis announces publication of preclinical data demonstrating superior protection by mucosally administered Mimopath®-based influenza vaccines http://www.medsciencescapital.com/news/mucosis-announces-publication-of-preclinical-data-demonstrating-superior-protection-by-mucosally-administered-mimopath-based-influenza-vaccines/ http://www.medsciencescapital.com/news/mucosis-announces-publication-of-preclinical-data-demonstrating-superior-protection-by-mucosally-administered-mimopath-based-influenza-vaccines/#comments Thu, 03 May 2012 15:42:54 +0000 piet http://www.medsciencescapital.com/?p=1148 http://www.medsciencescapital.com/news/mucosis-announces-publication-of-preclinical-data-demonstrating-superior-protection-by-mucosally-administered-mimopath-based-influenza-vaccines/feed/ 0 Pronota Strengthens Management Team: Former VP Corporate Development Genzyme joins as CBO http://www.medsciencescapital.com/news/pronota-strengthens-management-team-former-vp-corporate-development-genzyme-joins-as-cbo/ http://www.medsciencescapital.com/news/pronota-strengthens-management-team-former-vp-corporate-development-genzyme-joins-as-cbo/#comments Fri, 16 Mar 2012 13:42:47 +0000 piet http://www.medsciencescapital.com/?p=1135 http://www.medsciencescapital.com/news/pronota-strengthens-management-team-former-vp-corporate-development-genzyme-joins-as-cbo/feed/ 0 Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/ http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/#comments Wed, 25 Jan 2012 08:57:36 +0000 piet http://www.medsciencescapital.com/?p=1128 http://www.medsciencescapital.com/news/prosensa-raises-e23-million-in-new-equity-financing-led-by-new-enterprise-associates/feed/ 0 Pronota announces EUR 3.7 million Series C financing; management and board changes http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/ http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/#comments Fri, 20 Jan 2012 15:24:59 +0000 piet http://www.medsciencescapital.com/?p=1118 http://www.medsciencescapital.com/news/pronota-announces-eur-3-7-million-series-c-financing-management-and-board-changes/feed/ 0 Prosensa to Receive $1.5m from Charley’s Fund for Skipping of Exon 52 in Duchenne Muscular Dystrophy Patients http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/ http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/#comments Thu, 01 Dec 2011 09:06:38 +0000 piet http://www.medsciencescapital.com/?p=1108 http://www.medsciencescapital.com/news/prosensa-to-receive-1-5m-from-charley%e2%80%99s-fund-for-skipping-of/feed/ 0 Prosensa Updates on Patent Position http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/ http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/#comments Fri, 18 Nov 2011 15:53:49 +0000 piet http://www.medsciencescapital.com/?p=1079 http://www.medsciencescapital.com/news/prosensa-updates-on-patent-position/feed/ 0 Mucosis Announces New Scientific Advisory Board http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/ http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/#comments Tue, 15 Nov 2011 10:15:01 +0000 piet http://www.medsciencescapital.com/?p=1075 http://www.medsciencescapital.com/news/mucosis-announces-new-scientific-advisory-board/feed/ 0 Prosensa named Most Innovative European Biotech SME http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/ http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/#comments Tue, 08 Nov 2011 16:53:17 +0000 piet http://www.medsciencescapital.com/?p=1069 http://www.medsciencescapital.com/news/prosensa-named-most-innovative-european-biotech-sme/feed/ 0 Prosensa Awarded up to €5m Innovation Credit from Dutch Government for research in Myotonic Dystrophy http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/ http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/#comments Tue, 25 Oct 2011 09:24:37 +0000 piet http://www.medsciencescapital.com/?p=1053 http://www.medsciencescapital.com/news/prosensa-awarded-up-to-e5m-innovation-credit-from-dutch-government-for-research-in-myotonic-dystrophy/feed/ 0